DNA diagnosis and the emergence of cancer-genetic services in european health care

Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

Standard

DNA diagnosis and the emergence of cancer-genetic services in european health care. / Bourret, Pascale; Koch, Lene; Stemerding, Dirk.

The Social Management of Genetic Engineering. Taylor and Francis/Routledge, 2019. p. 117-138.

Research output: Chapter in Book/Report/Conference proceedingBook chapterResearchpeer-review

Harvard

Bourret, P, Koch, L & Stemerding, D 2019, DNA diagnosis and the emergence of cancer-genetic services in european health care. in The Social Management of Genetic Engineering. Taylor and Francis/Routledge, pp. 117-138. https://doi.org/10.4324/9780429423499-7

APA

Bourret, P., Koch, L., & Stemerding, D. (2019). DNA diagnosis and the emergence of cancer-genetic services in european health care. In The Social Management of Genetic Engineering (pp. 117-138). Taylor and Francis/Routledge. https://doi.org/10.4324/9780429423499-7

Vancouver

Bourret P, Koch L, Stemerding D. DNA diagnosis and the emergence of cancer-genetic services in european health care. In The Social Management of Genetic Engineering. Taylor and Francis/Routledge. 2019. p. 117-138 https://doi.org/10.4324/9780429423499-7

Author

Bourret, Pascale ; Koch, Lene ; Stemerding, Dirk. / DNA diagnosis and the emergence of cancer-genetic services in european health care. The Social Management of Genetic Engineering. Taylor and Francis/Routledge, 2019. pp. 117-138

Bibtex

@inbook{1d3cac4b4915402184b6f1e39be40c7b,
title = "DNA diagnosis and the emergence of cancer-genetic services in european health care",
abstract = "This chapter focuses on cancer genetics as a field in which the extension of options for genetic testing is already clearly visible and which thus allows to study the implications of this development on an empirical level. It presents the introduction of deoxyribonucleic acid (DNA) diagnosis in the clinic as a complex process of sociotechnical change in which technical innovation is going together with the development of new skills, new relations between the clinic and the laboratory, new relations between professions, new forms of demand, new guidelines. In the context of established screening programmes for familial adenomatous polyposis, the introduction of DNA diagnosis in the early 1990s was generally seen as an opportunity to improve the organization of screening. The introduction of DNA diagnosis of hereditary breast and/or ovarian cancer is linked to initiatives which will further enhance awareness of familial breast and/or ovarian cancer risks and which will also generate increasing demand for a DNA diagnostic test.",
author = "Pascale Bourret and Lene Koch and Dirk Stemerding",
year = "2019",
doi = "10.4324/9780429423499-7",
language = "English",
isbn = "9780429423499",
pages = "117--138",
booktitle = "The Social Management of Genetic Engineering",
publisher = "Taylor and Francis/Routledge",

}

RIS

TY - CHAP

T1 - DNA diagnosis and the emergence of cancer-genetic services in european health care

AU - Bourret, Pascale

AU - Koch, Lene

AU - Stemerding, Dirk

PY - 2019

Y1 - 2019

N2 - This chapter focuses on cancer genetics as a field in which the extension of options for genetic testing is already clearly visible and which thus allows to study the implications of this development on an empirical level. It presents the introduction of deoxyribonucleic acid (DNA) diagnosis in the clinic as a complex process of sociotechnical change in which technical innovation is going together with the development of new skills, new relations between the clinic and the laboratory, new relations between professions, new forms of demand, new guidelines. In the context of established screening programmes for familial adenomatous polyposis, the introduction of DNA diagnosis in the early 1990s was generally seen as an opportunity to improve the organization of screening. The introduction of DNA diagnosis of hereditary breast and/or ovarian cancer is linked to initiatives which will further enhance awareness of familial breast and/or ovarian cancer risks and which will also generate increasing demand for a DNA diagnostic test.

AB - This chapter focuses on cancer genetics as a field in which the extension of options for genetic testing is already clearly visible and which thus allows to study the implications of this development on an empirical level. It presents the introduction of deoxyribonucleic acid (DNA) diagnosis in the clinic as a complex process of sociotechnical change in which technical innovation is going together with the development of new skills, new relations between the clinic and the laboratory, new relations between professions, new forms of demand, new guidelines. In the context of established screening programmes for familial adenomatous polyposis, the introduction of DNA diagnosis in the early 1990s was generally seen as an opportunity to improve the organization of screening. The introduction of DNA diagnosis of hereditary breast and/or ovarian cancer is linked to initiatives which will further enhance awareness of familial breast and/or ovarian cancer risks and which will also generate increasing demand for a DNA diagnostic test.

U2 - 10.4324/9780429423499-7

DO - 10.4324/9780429423499-7

M3 - Book chapter

AN - SCOPUS:33645774810

SN - 9780429423499

SP - 117

EP - 138

BT - The Social Management of Genetic Engineering

PB - Taylor and Francis/Routledge

ER -

ID: 241102838